Cargando…

Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays

SARS-CoV-2 main protease (M(pro)) is one of the most extensively exploited drug targets for COVID-19. Structurally disparate compounds have been reported as M(pro) inhibitors, raising the question of their target specificity. To elucidate the target specificity and the cellular target engagement of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Chunlong, Tan, Haozhou, Choza, Juliana, Wang, Yuyin, Wang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558150/ https://www.ncbi.nlm.nih.gov/pubmed/34745850 http://dx.doi.org/10.1016/j.apsb.2021.10.026

Ejemplares similares

Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor
por: Tan, Haozhou, et al.
Publicado: (2022)

Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor
por: Tan, Haozhou, et al.
Publicado: (2022)

FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro)
por: Tan, Haozhou, et al.
Publicado: (2023)

Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2022)

Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay
por: Xia, Zilei, et al.
Publicado: (2021)

Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
por: Ma, Chunlong, et al.
Publicado: (2021)

A Novel Bioluminescent Protease Assay Using Engineered Firefly Luciferase
por: Wigdal, Susan S, et al.
Publicado: (2008)

Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2021)

Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir
por: Hu, Yanmei, et al.
Publicado: (2022)

Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir
por: Hu, Yanmei, et al.
Publicado: (2023)

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate()
por: Kuo, Chih-Jung, et al.
Publicado: (2004)

Using multiplexed regulation of luciferase activity and GFP translocation to screen for FOXO modulators
por: Zanella, Fabian, et al.
Publicado: (2009)

A Novel Method for High-Level Production of TEV Protease by Superfolder GFP Tag
por: Wu, Xudong, et al.
Publicado: (2009)

Glycolate Oxidase Isozymes Are Coordinately Controlled by GLO1 and GLO4 in Rice
por: Zhang, Zhisheng, et al.
Publicado: (2012)

Structural dynamics of COVID-19 main protease
por: Shekaari, Ashkan, et al.
Publicado: (2021)

Quaternary Structure of the SARS Coronavirus Main Protease
por: Chang, Gu-Gang
Publicado: (2009)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

Development of a luciferase-based biosensor to assess enterovirus 71 3C protease activity in living cells
por: Zhang, Yuan, et al.
Publicado: (2017)

Molecular modeling evaluation of the binding effect of five protease inhibitors to COVID-19 main protease
por: Liu, Jian, et al.
Publicado: (2021)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2
por: Ferreira, Juliana C., et al.
Publicado: (2020)

On validation and invalidation of biological models
por: Anderson, James, et al.
Publicado: (2009)

Assessing activity of Hepatitis A virus 3C protease using a cyclized luciferase-based biosensor
por: Zhou, Junwei, et al.
Publicado: (2017)

NanoLuc Luciferase as a Fluorogen-Activating Protein for GFP Chromophore Based Fluorogens
por: Bogdanova, Yulia A., et al.
Publicado: (2023)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
por: Mótyán, János András, et al.
Publicado: (2022)

Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)

Beyond the bench: go for the GLO.
por: O'Fallon, Liam
Publicado: (2004)

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

Individual and common inhibitors of coronavirus and picornavirus main proteases
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease
por: Behnam, Mira A. M., et al.
Publicado: (2021)

A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism
por: Ho, Chien-Yi, et al.
Publicado: (2022)

Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
por: Cardoso, Wesley B., et al.
Publicado: (2021)

Waltz para Glo : para cuarteto de cuerdas
por: Navarrete Ponce, Renato Pávelk
Publicado: (2004)

Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
por: Lin, Yuxi, et al.
Publicado: (2021)

Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors
por: Li, Zhe, et al.
Publicado: (2021)

A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir
por: Vankadara, Subramanyam, et al.
Publicado: (2022)

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease
por: Wang, Qian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m960k748b4acasr8gb21f7gocu